Michael R Harrison

10PUBLICATIONS
38CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Exercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 05, 2026
Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer.

|Jul 10, 2026
Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.

|Feb 22, 2024
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.

Ryan E Fecteau, Bridget F Koontz, Karen E Hoffman

|Mar 20, 2022
Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancer.

Erik D Hanson, Mohamdod Alzer, Jackson Carver

|Mar 16, 2022
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer.

Landon C Brown, Susan Halabi, Jason A Somarelli

|Mar 11, 2022
A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND).

Michael R Harrison, Paul G Davis, Michel G Khouri

Pageof 2

Frequent Collaborators

6 joint publications

Daniel J George

5 joint publications

Andrew J Armstrong

5 joint publications

Tian Zhang

4 joint publications

Lauren Howard